Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. AMTM
AMTM logo

AMTM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Amentum Holdings Inc (AMTM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
28.790
1 Day change
-4.98%
52 Week Range
38.110
Analysis Updated At
2026/03/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Amentum Holdings Inc (AMTM) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is experiencing a downward trend, hedge funds are selling heavily, and technical indicators do not suggest a clear entry point. While the company's net income and EPS have shown significant YoY growth, revenue has declined, and there are no recent positive news catalysts. Analyst ratings remain neutral, and there are no strong trading signals from Intellectia Proprietary Trading Signals. Given the investor's profile and the current data, holding off on buying is advisable.

Technical Analysis

The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 46.595, showing no clear signal. Moving averages are converging, and the stock is trading near its pivot point of 30.582, with support at 29.405 and resistance at 31.759. Overall, the technical indicators suggest a lack of strong upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market, but this is not supported by other data points such as price trends or hedge fund activity.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • Gross margin also improved slightly by 1.56% YoY.

Neutral/Negative Catalysts

  • Hedge funds are selling heavily, with a 3056.33% increase in selling activity last quarter. There is no recent news or congress trading data to suggest positive momentum. Analyst ratings remain neutral, with no significant upgrades.

Financial Performance

In Q1 2026, revenue dropped to $3.237 billion, down 5.24% YoY. However, net income increased significantly to $44 million, up 266.67% YoY. EPS rose to 0.18, up 260.00% YoY, and gross margin improved to 7.17%, up 1.56% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

BofA raised the price target to $30 from $27, maintaining a Neutral rating. The firm highlights improved investor sentiment and the company's nuclear exposure but notes uncertainties in civilian agency funding heading into 2026.

Wall Street analysts forecast AMTM stock price to rise
9 Analyst Rating
Wall Street analysts forecast AMTM stock price to rise
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 30.300
sliders
Low
30
Averages
35.75
High
40
Current: 30.300
sliders
Low
30
Averages
35.75
High
40
BofA
Neutral
maintain
$27 -> $30
AI Analysis
2025-12-31
Reason
BofA
Price Target
$27 -> $30
AI Analysis
2025-12-31
maintain
Neutral
Reason
BofA raised the firm's price target on Amentum to $30 from $27 and keeps a Neutral rating on the shares. The firm cites improved investor sentiment and the company's market premium for its nuclear exposure for the target increase. Amentum benefits from a nuclear premium, the analyst tells investors in a research note. Heading into 2026, BofA expects defense and intelligence funding to remain strong, while civilian agency funding "remains a question mark."
BTIG
Buy
maintain
$30 -> $35
2025-12-03
Reason
BTIG
Price Target
$30 -> $35
2025-12-03
maintain
Buy
Reason
BTIG raised the firm's price target on Amentum to $35 from $30 and keeps a Buy rating on the shares. The company's legacy verticals - RDT&E, Intelligence Operations & Analysis, Homeland Security/Border Protection, Environmental Remediation, and Defense Engineering, Logistics & Modernization - generate $10B in sales with mid-to-high single digit margins and low-to-mid single digit growth, and this core foundation enables expansion into high-growth areas like Space Systems & Technologies, Critical Digital Infrastructure, and Global Nuclear Energy, which are expected to grow faster and drive overall margin expansion due to their accretive nature, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AMTM
Unlock Now

People Also Watch